227 related articles for article (PubMed ID: 19959513)
21. Detection of prostate cancer with MR spectroscopic imaging: an expanded paradigm incorporating polyamines.
Shukla-Dave A; Hricak H; Moskowitz C; Ishill N; Akin O; Kuroiwa K; Spector J; Kumar M; Reuter VE; Koutcher JA; Zakian KL
Radiology; 2007 Nov; 245(2):499-506. PubMed ID: 17890357
[TBL] [Abstract][Full Text] [Related]
22. Characterization of musculoskeletal lesions on 3-T proton MR spectroscopy.
Fayad LM; Barker PB; Jacobs MA; Eng J; Weber KL; Kulesza P; Bluemke DA
AJR Am J Roentgenol; 2007 Jun; 188(6):1513-20. PubMed ID: 17515370
[TBL] [Abstract][Full Text] [Related]
23. In vivo proton MR spectroscopy of the breast.
Stanwell P; Mountford C
Radiographics; 2007 Oct; 27 Suppl 1():S253-66. PubMed ID: 18180231
[TBL] [Abstract][Full Text] [Related]
24. Short echo time MR spectroscopy of brain tumors: grading of cerebral gliomas by correlation analysis of normalized spectral amplitudes.
Weis J; Ring P; Olofsson T; Ortiz-Nieto F; Wikström J
J Magn Reson Imaging; 2010 Jan; 31(1):39-45. PubMed ID: 20027571
[TBL] [Abstract][Full Text] [Related]
25. Restoration of motion-related signal loss and line-shape deterioration of proton MR spectra using the residual water as intrinsic reference.
Helms G; Piringer A
Magn Reson Med; 2001 Aug; 46(2):395-400. PubMed ID: 11477645
[TBL] [Abstract][Full Text] [Related]
26. Quantitative magnetic resonance methods for in vivo investigation of the human liver and spleen. Technical aspects and preliminary clinical results.
Thomsen C
Acta Radiol Suppl; 1996; 401():1-34. PubMed ID: 8604619
[TBL] [Abstract][Full Text] [Related]
27. Proton MR spectroscopy with choline peak as malignancy marker improves positive predictive value for breast cancer diagnosis: preliminary study.
Bartella L; Morris EA; Dershaw DD; Liberman L; Thakur SB; Moskowitz C; Guido J; Huang W
Radiology; 2006 Jun; 239(3):686-92. PubMed ID: 16603660
[TBL] [Abstract][Full Text] [Related]
28. Proton MR spectroscopy in metabolic assessment of musculoskeletal lesions.
Subhawong TK; Wang X; Durand DJ; Jacobs MA; Carrino JA; Machado AJ; Fayad LM
AJR Am J Roentgenol; 2012 Jan; 198(1):162-72. PubMed ID: 22194493
[TBL] [Abstract][Full Text] [Related]
29. Quantification of non-water-suppressed MR spectra with correction for motion-induced signal reduction.
Lin JM; Tsai SY; Liu HS; Chung HW; Mulkern RV; Cheng CM; Yeh TC; Chen NK
Magn Reson Med; 2009 Dec; 62(6):1394-403. PubMed ID: 19780180
[TBL] [Abstract][Full Text] [Related]
30. Discrimination of brain abscess and cystic tumor by in vivo proton magnetic resonance spectroscopy.
Kadota O; Kohno K; Ohue S; Kumon Y; Sakaki S; Kikuchi K; Miki H
Neurol Med Chir (Tokyo); 2001 Mar; 41(3):121-6. PubMed ID: 11372554
[TBL] [Abstract][Full Text] [Related]
31. Characterization of intracranial mass lesions with in vivo proton MR spectroscopy.
Poptani H; Gupta RK; Roy R; Pandey R; Jain VK; Chhabra DK
AJNR Am J Neuroradiol; 1995 Sep; 16(8):1593-603. PubMed ID: 7502961
[TBL] [Abstract][Full Text] [Related]
32. Further development in anatomically constrained MR image reconstruction: application to multimodal imaging of mouse stroke.
Haldar JP; Wu TH; Wang Q; Chen CI; Song SK; Liang ZP
Annu Int Conf IEEE Eng Med Biol Soc; 2008; 2008():422-5. PubMed ID: 19162683
[TBL] [Abstract][Full Text] [Related]
33. Combined use of diffusion-weighted MRI and 1H MR spectroscopy to increase accuracy in prostate cancer detection.
Reinsberg SA; Payne GS; Riches SF; Ashley S; Brewster JM; Morgan VA; deSouza NM
AJR Am J Roentgenol; 2007 Jan; 188(1):91-8. PubMed ID: 17179350
[TBL] [Abstract][Full Text] [Related]
34. Navigator based respiratory gating during acquisition and preparation phases for proton liver spectroscopy at 3 T.
Hock A; Valkovič L; Geier A; Kuntzen T; Boesiger P; Henning A
NMR Biomed; 2014 Mar; 27(3):348-55. PubMed ID: 24591124
[TBL] [Abstract][Full Text] [Related]
35. Quantitative determination of liver triglyceride levels with 3T ¹H-MR spectroscopy in mice with moderately elevated liver fat content.
Runge JH; Bakker PJ; Gaemers IC; Verheij J; Hakvoort TB; Ottenhoff R; Stoker J; Nederveen AJ
Acad Radiol; 2014 Nov; 21(11):1446-54. PubMed ID: 25300722
[TBL] [Abstract][Full Text] [Related]
36. Molecular characterization of musculoskeletal tumors by proton MR spectroscopy.
Fayad LM; Barker PB; Bluemke DA
Semin Musculoskelet Radiol; 2007 Sep; 11(3):240-5. PubMed ID: 18260034
[TBL] [Abstract][Full Text] [Related]
37. In vivo single-voxel proton MR spectroscopy in the differentiation of high-grade gliomas and solitary metastases.
Fan G; Sun B; Wu Z; Guo Q; Guo Y
Clin Radiol; 2004 Jan; 59(1):77-85. PubMed ID: 14697379
[TBL] [Abstract][Full Text] [Related]
38. Manually adjusted versus vendor-preset definition of metabolite boundaries impact on proton metabolite ratios.
Petrou M; Sundgren PC; Pang Y; Rohrer S; Foerster B; Chenevert TL
Acad Radiol; 2007 Mar; 14(3):340-3. PubMed ID: 17307667
[TBL] [Abstract][Full Text] [Related]
39. Mapping of brain metabolite distributions by volumetric proton MR spectroscopic imaging (MRSI).
Maudsley AA; Domenig C; Govind V; Darkazanli A; Studholme C; Arheart K; Bloomer C
Magn Reson Med; 2009 Mar; 61(3):548-59. PubMed ID: 19111009
[TBL] [Abstract][Full Text] [Related]
40. In vivo differentiation of aerobic brain abscesses and necrotic glioblastomas multiforme using proton MR spectroscopic imaging.
Lai PH; Weng HH; Chen CY; Hsu SS; Ding S; Ko CW; Fu JH; Liang HL; Chen KH
AJNR Am J Neuroradiol; 2008 Sep; 29(8):1511-8. PubMed ID: 18499784
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
